Stomach Cancer Diagnosis Announced by NZ Government Pfizer Representative Nigel Latta

14 October 2021: "Do you still have questions about the Pfizer vaccine you’d like answered before you’re vaccinated? On Wednesday 13 October Nigel Latta, Dr Maia Brewerton and Dr Helen Petousis-Harris answered your questions."
______________
After representing Pfizer on behalf of the NZ government in 2021, almost exactly three years later, in September 2024, psychologist Nigel Latta has announced that he has been diagnosed with terminal stomach cancer.
https://www.1news.co.nz/2024/09/06/prominent-tv-psychologist-nigel-latta-diagnosed-with-cancer/

Many pharmaceutical company agents are now facing terminal illness. They were used and their lives meant nothing to the criminals doing this. DNA Contamination in the vials is ensuring an explosion in cancer at the same time that Pfizer have invested in cancer drug development company Seagen. In 2022 Seagen made a US$2 billion turnover. Pfizer purchased them for US$43 billion. That is an act of confidence.

Meanwhile, ethical doctors are talking about successful cancer treatment regimes using repurposed drugs such as ivermectin, fenbendazole and mebendazole. For example:
https://rumble.com/v5ef32b-ivermectin-can-cure-cancer-oncologist-dr-kathleen-ruddy.html?e9s=src_v1_ucp
and
https://makismd.substack.com/p/fenbendazole-success-story-denise

Nigel Latta appears in this video alongside state funded Stuff journalist, Patrick (Paddy) Gower, speaking with the following "experts" who are, or are likely to be, on specific payrolls, funded to promote an agenda.

Gates Foundation funded vaccinologist Helen Petousis-Harris tells New Zealanders that she took Pfizer's product because "I don't want to get dead". Some believe she is an unnamed (and unelected) face photographed representing New Zealand at World Health Organization global legislation meetings in Geneva (https://www.globalvaccinedatanetwork.org/aboutus/our-funding).

Maia Brewerton is an immunologist with the private Malaghan Institute of Medical Research (https://www.malaghan.org.nz/). It is not clear where the Malaghan Institute get their funding, but their 2023 annual report shows their funding almost doubled from 23 million in 2022, to 39 million in 2023. Rewards for promoting pharmaceutical products are a potential reason for this sudden boom, but without transparency of funding sources this is only supposition.

VIDEO SOURCE: https://www.youtube.com/watch?v=SVkxPHhq2FU